Milrinone and other inotropic agents in cardiogenic shock

Rebecca Mathew and Pietro Di Santo, from Ottawa, Toronto, lead investigators of the recently published DOREMI trial, discuss the current place of milrinone and other pharmacologic agents in the management of cardiogenic shock.
If you’ve found this chat interesting and would like to be included on our mailing list for future educational events in the fields of intensive care and emergency medicine, please click on the link to complete your name and email address: www.isicem.org...
For more ISICEM chats, go to isicem.org/e-c...
Follow ISICEM on Twitter: / isicem​​​​​​​
Like ISICEM on Facebook: / isicem.org​​. .
Subscribe to our channel: www.youtube.co...